📰 Reset Pharma News
Reset Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reset Pharma. Real-time updates on events, politics, business and more.
November 1, 2023
Company may now initiate Phase 2b trial for treatment of demoralization syndrome in patients with cancerNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health conditions related to life-altering diseases, today announces that the Company has received a Safe to Proceed notification from the U.S. Food and Drug Administration (FDA) regarding its Invest
September 1, 2023
Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce a significant licensing agreement between Filament Health and Reset...
March 16, 2023
Private psychedelics companies have raised hundreds of millions of dollars. Here are the biggest venture investors backing their efforts.
January 5, 2023
EQS-News: Reset Pharmaceuticals, Inc. / Key word(s): Personnel Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer 05.01.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Reset Pharmaceuticals Appoints Innes Meldrum as...
November 2, 2022
EQS-News: Reset Pharmaceuticals, Inc. / Key word(s): Personnel Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors 02.11.2022 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Reset Pharmaceut...
July 14, 2022
/PRNewswire/ -- Iter Investments, a venture capital firm that aims to deploy capital primarily in businesses operating in and around the burgeoning psychedelic...